Olive Leaf Extract Enhances Natural Killer Cell-Mediated Cytotoxicity against Colorectal Cancer Cells

Gulnihal Sisman1, Ayfer Sendul2, Abdurrahim Kocyigit3

  • 1Bezmialem Vakıf University, Health Sciences Instute, Department of Medical Biochemistry, Istanbul, Turkey.

Abstract

Insights

Olive Leaf Extract (OLE) enhances Natural Killer (NK) cell activity against colorectal cancer (CRC) cells. This study shows OLE boosts NK-cell cytotoxicity at physiologically achievable doses, offering a promising CRC therapeutic strategy.

Area of Science:

  • Immunology
  • Oncology
  • Natural Products Chemistry

Background:

  • Natural Killer (NK) cells are crucial for eliminating malignant cells through cytotoxicity.
  • Olive Leaf Extract (OLE), rich in oleuropein and hydroxytyrosol, has shown direct anticancer effects.
  • OLE's therapeutic potential is limited by poor bioavailability, necessitating high concentrations for direct action.

Purpose of the Study:

  • To investigate the potential of Olive Leaf Extract (OLE) to enhance NK-92 cell-mediated cytotoxicity against HT-29 colorectal cancer cells.
  • To evaluate the immunomodulatory effects of OLE on NK cells in a co-culture system.

Main Methods:

  • Olive leaves were extracted using 70% methanol.
  • Cell viability was assessed using MTT and ATP assays.
  • NK-92 cell cytotoxicity against HT-29 cells was measured in co-culture, with Granzyme B and perforin levels quantified via ELISA.

Main Results:

  • OLE inhibited HT-29 cell proliferation in a dose-dependent manner (IC₅₀ = 548 µg/mL).
  • Low OLE concentrations (100-200 µg/mL) promoted NK-92 cell proliferation, while higher concentrations were cytotoxic.
  • OLE significantly enhanced NK-92-mediated cytotoxicity against HT-29 cells at non-toxic concentrations, correlating with increased Granzyme B and perforin levels.

Conclusions:

  • OLE demonstrates potential as an immunomodulatory agent to enhance innate antitumor immunity.
  • OLE can elicit potent anticancer responses via NK cells at lower, physiologically achievable doses.
  • This suggests a promising therapeutic strategy for colorectal cancer leveraging OLE's effects on NK-cell function.